BBIO · BridgeBio Pharma, Inc. · Fails to Deliver
Market Cap
$13.37B
Shares
195.49M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-25 | 57 | $81.07 | $4,621 |
| 2026-08-24 | 35 | $81.50 | $2,853 |
| 2026-08-05 | 15,279 | $82.07 | $1,253,948 |
| 2026-07-28 | 10 | $84.12 | $841 |
| 2026-07-24 | 100 | $82.93 | $8,293 |
| 2026-07-23 | 100 | $82.66 | $8,266 |
| 2026-07-22 | 100 | $82.45 | $8,245 |
| 2026-07-20 | 185 | $81.38 | $15,055 |
| 2026-07-17 | 4 | $80.30 | $321 |
| 2026-07-08 | 7,800 | $77.91 | $607,698 |
| 2026-07-01 | 60 | $74.48 | $4,469 |
| 2026-06-30 | 1,697,839 | $72.01 | $122,261,386 |
| 2026-06-29 | 1,647,278 | $70.24 | $115,704,807 |
| 2026-06-26 | 93 | $69.69 | $6,481 |
| 2026-06-25 | 522 | $69.36 | $36,206 |
Showing 1–15 of 15 settlements
Key facts
CIK
1743881
CUSIP
10806X102
13F (30d)
15 filings
12 filers
Visit website
Investor relations